Tevogen Inc. (NASDAQ:TVGN)
| Market Cap | 27.03M-82.1% |
| Revenue (ttm) | 0 |
| Net Income | -21.61M+30.4% |
| EPS | -5.83+36.1% |
| Shares Out | 4.16M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,693 |
| Open | 6.90 |
| Previous Close | 6.49 |
| Day's Range | 6.49 - 7.10 |
| 52-Week Range | 3.64 - 39.00 |
| Beta | 0.20 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |
Insiders here have filed 14 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About TVGN
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$TVGN stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in TVGN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by TVGN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
TVGN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New TVGN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to TVGN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in TVGN
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $105.41K |
| VXFVanguard Extended Market ETF | $12.84K |
Estimated from each fund’s disclosed top holdings × AUM
TVGN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from TVGN’s recent data — informational, not investment advice